MLN and Parkinson disease: A study assessing the postprandial secretion of pancreatic polypeptide and motilin involving 10 iRBD patients, 38 PD patients (19 of them drug-naïve), and 10 controls, showed a physiological pattern in all study groups, with a mild enhanced response in PD and iRBD [126].